Zejing Pharmaceutical (688266.SH): Gicaxitinib hydrochloride tablets included in the 2025 National Medical Insurance Drug List

Zhitongcaijing · 2d ago

According to Zhitong Finance App, Zejing Pharmaceutical (688266.SH issued an announcement. On December 7, 2025, the National Medical Security Administration and the Ministry of Human Resources and Social Security announced the “National Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalogue (2025)” (hereinafter referred to as the “National Medical Insurance Drug Catalogue”). The company's self-developed gemaxitinib hydrochloride tablets were included in the national medical insurance drug catalogue through national health insurance negotiations. The 2025 National Medical Insurance Drug List will be implemented on January 1, 2026.

The inclusion of gikaxitinib hydrochloride tablets in the national medical insurance drug catalogue will benefit product sales and have a positive impact on the company's long-term business development. It is expected that it will not have a significant impact on business performance in the short term.